Data released today show that MR-guided focused ultrasound (MRgFUS) is a more effective option for a broader population of uterine fibroid sufferers.
A new study in mice raises a tantalizing possibility — that humans may one day be able to eat any kind of fat they want without raising their risk of heart disease.
GlaxoSmithKline [GSK: NYSE] commended the commitment of the World Health Organization (WHO) to progress plans for ensuring that the world?s most vulnerable people are protected in the event of a pandemic. Key elements of that commitment include progress being made towards the development of an H5N1 vaccine global stockpile by the WHO, and efforts to establish an additional mechanism to ensure broader access to pandemic influenza vaccine for developing world countries.
Barr Laboratories, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), announced that it received final U.S. Food & Drug Administration (FDA) approval for its application to manufacture and market a generic version of Bayer Pharmaceuticals Corporation’s Nimotop(R) (nimodipine) Capsules, 30 mg.
Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. (NYSE: BRL), announced that the Company has received two U.S. Food and Drug Administration (FDA) approvals related to its ENJUVIA(TM) (synthetic conjugated estrogens, B) product.
Today, nearly 40 of the US’s top business leaders and largest employers joined forces to announce the formation of the Coalition to Advance Healthcare Reform (CAHR). Standing shoulder to shoulder with lawmakers at a Capitol Hill press conference, they discussed the coalition’s core principles, its mission and called for meaningful federal and state policy reforms by 2009 to solve the nation’s healthcare crisis.
Heart attack is linked to a common genetic variation on chromosome 9p21. This genetic mutation increases heart attack risk, revealed by researchers at at Emory and Duke Universities.
As Abbott Laboratories concluded its Annual General Meeting in Chicago, advocates from AIDS Healthcare Foundation (AHF), the US’ largest HIV/AIDS healthcare, prevention and education provider, which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, continued to press Abbott to rollback its punitive drug blacklist against Thailand on six new Abbott medicines and drop its demand that Thailand rescind a compulsory license for a generic version of another blacklisted Abbott drug, Aluvia, in order to access Abbott’s version of the lifesaving AIDS drug at a significantly reduced price from the company.
The U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) continue their investigation of imported rice protein concentrate which has been found to contain melamine and melamine-related compounds.
Adding a new dimension to its business, the Mukesh Ambani-led Reliance Life Sciences announced its partnership with US-based global investment management firm, MPM Capital LP.